She serves as a key faculty member, contributing to the center’s mission of reducing the cancer burden through precision medicine and community outreach.
Dr. Fejerman has held significant roles at major research institutions, bridging the gap between genomic science and public health.
Beyond the laboratory, Dr. Fejerman is a dedicated advocate for health equity. She co-developed a specialized program alongside (founder of the Latino Cancer Institute) to educate Spanish-speaking communities about hereditary breast cancer. Ada Marta Fejerman
– Research detailing how ancestry-driven biological factors impact survival rates.
Dr. Fejerman’s research is best known for exploring how influences breast cancer susceptibility and survival. She serves as a key faculty member, contributing
– A pivotal study identifying genetic variants unique to the Latina population.
A major focus of her lab is the refinement of Polygenic Risk Scores (PRS) , ensuring these tools are accurate for diverse populations rather than relying solely on data from individuals of European descent. Community Impact and "Promotores" Programs Beyond the laboratory, Dr
As the principal investigator, she oversees research into breast cancer genetics, specifically investigating common risk-associated genetic variants and the development of polygenic risk scores (PRS) tailored for women of Latin American heritage.
Before her time at UC Davis, she was a prominent researcher at the University of California, San Francisco (UCSF) , where she initiated much of her foundational work on genetic admixture and cancer disparities. Groundbreaking Research: Ancestry and Breast Cancer